Calcite Single Crystals as Hosts for Atomic-Scale Entrapment and Slow Release of Drugs

Adv Healthc Mater. 2015 Jul 15;4(10):1510-6. doi: 10.1002/adhm.201500170. Epub 2015 Jun 1.

Abstract

Doxorubicin (DOX)/CaCO3 single crystals act as pH responsive drug carrier. A biomimetic approach demonstrates that calcite single crystals are able, during their growth in the presence of doxorubicin, to entrap drug molecules inside their lattice along specific crystallographic directions. Alterations in lattice dimensions and microstructural parameters are determined by means of high-resolution synchrotron powder diffraction measurements. Confocal microscopy confirms that doxorubicin is uniformly embedded in the crystal and is not simply adsorbed on the crystal surface. A slow release of DOX was obtained preferentially in the proximity of the crystals, targeting cancer cells.

Keywords: calcium carbonate; doxorubicin; drug carriers; high-resolution synchrotron powder diffraction; intracrystalline.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Calcium Carbonate / chemistry*
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Crystallization
  • Doxorubicin / chemistry*
  • Doxorubicin / toxicity
  • Drug Carriers / chemistry*
  • Humans
  • Microscopy, Confocal
  • Microscopy, Electron, Scanning

Substances

  • Drug Carriers
  • Doxorubicin
  • Calcium Carbonate